BridgeMD
New treatment option for Glucose Metabolism Disorders
Official title Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy Subjects
ClinicalTrials.gov ID: NCT06051318
What this study is testing
- What it's testing
- When all the food we eat is digested, it will increase blood glucose. Two people can have different glucose blood levels to the same food and one reason can be bacteria live in our gut.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- BMI \> 18.5 and \< 30
- Willing to use an intradermal continuous glucose monitoring sensor during the 10-day study
- Own a mobile phone with NFC technology
- Willing to provide a fecal swab sample and a stool sample
- Understanding, agreement, and signing of the approved Informed Consent Form (ICF) by the Ethics Committee (CEP)
You likely can't join if
- Pregnant or lactating women
- Diagnosis of any gastrointestinal disorder or disease (Irritable Bowel Syndrome, Ulcerative Colitis, Crohn's Disease)
- Intolerance or allergy to any diet ingredient
- Autoimmune disorder (Lupus, Type 1 Diabetes, Celiac Disease) or infectious disease
- Diabetes diagnosis
- Cancer diagnosis, acute myocardial infarction, or stroke in the last 6 months
See the full eligibility criteria
- BMI \> 18.5 and \< 30
- Willing to use an intradermal continuous glucose monitoring sensor during the 10-day study
- Own a mobile phone with NFC technology
- Willing to provide a fecal swab sample and a stool sample
- Understanding, agreement, and signing of the approved Informed Consent Form (ICF) by the Ethics Committee (CEP)
- Pregnant or lactating women
- Diagnosis of any gastrointestinal disorder or disease (Irritable Bowel Syndrome, Ulcerative Colitis, Crohn's Disease)
- Intolerance or allergy to any diet ingredient
- Autoimmune disorder (Lupus, Type 1 Diabetes, Celiac Disease) or infectious disease
- Diabetes diagnosis
- Cancer diagnosis, acute myocardial infarction, or stroke in the last 6 months
- Use of hypoglycemic medication
- Use of proton pump inhibitors, immunosuppressants, or antimicrobials in the last 3 months
- Use of laxative medications in the last 30 days
- Underwent invasive procedures or surgery in the last 6 months
- Admission to ICU in the last 2 years
- Participation in any experimental study or ingestion of any experimental drug within twelve months prior to the start of this study, in accordance with RDC 251/97
- Inability to read and understand the informed consent form
The study team makes the final eligibility decision.
Where it's taking place
- Florianópolis, Santa Catarina, Brazil
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Florianópolis, Santa Catarina, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.